South Korean researchers have, for the first time in the world, uncovered how messenger ribonucleic acid (mRNA) vaccines ...

Kim V. Narry, director of the Center for RNA Research of the Institute for Basic Science and chair professor at the ...

Moderna (NasdaqGS:MRNA) experienced a significant decline of 19% over the past week. This drop can largely be attributed to broader market turbulence, amplified by the steep fall in major indices such ...

Customers looking for an mRNA therapeutic partner should prioritize operational excellence and choose flexible CDMOs.

MRNA technology is facing growing doubts among Republicans. This is a KFF Health News story. Researchers racing to develop bird flu vaccines for humans have turned to a cutting-edge technology ...

A team of researchers has uncovered a key cellular mechanism that affects the function of mRNA vaccines and therapeutics. Their study provides the first comprehensive understanding of how mRNA ...

Sunshine Biopharma's K1.1 mRNA-LNP shows promise for HCC treatment in mice, while its 2024 revenue surged 45% to $34.9 ...

Scientists at Shinshu University School of Medicine have developed a synthetic mRNA that, when injected, revitalizes the immune system to recognize and attack metastasizing cancer cells.

Sunshine Biopharma (SBFM) has completed additional studies on orthotopic human tumor models in mice confirming its K1.1 mRNA Lipid ...